ArticleJournal of neurology2022

Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia.

Tianjiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.